HEALTH OF WOMAN. 2020.9-10(155-156): 50-53; doi 10.15574/HW.2020.155-156.50
Alirzayeva Kh.
Azerbaijan State Institute for Advanced Training of Doctors named after A. Aliyeva, Baku

The objective: to determine the risk factors for the development of ESRD in pregnant women with preeclampsia and anemia.
Materials and methods. 97 pregnant women with preeclampsia with iron-deficiency anemia were monitored. The first group included 46 pregnant women with diagnosed ZRD, the second group-51 pregnant women who gave birth to children with normal body weight. Criteria of FGR is to reduce body weight and length of newborn at birth (less than 10 percentile of assessment tables in comparison with due to gestational age), morphological maturity index (a lag of 2 weeks or more from the true gestational age), disproportionate body, the signs of malnutrition and trophic disorders of the skin and mucous membranes.
Results. A step-by-step elimination of the factors that contributed the least to the development of ARI in a combination of preeclampsia and anemia was performed. The results of multivariate analysis showed that in General, the following factors had the strongest influence on the development of RR in preeclampsia and anemia: arterial hypertension (RR= 2.055 [95% CI 1.31-3.20]), overweight/obesity (RR=1.646 [95% CI 1.03-2.62]), anemia in the anamnesis (RR=2.591[95% CI 1.56-4.28]),complicated labor in the anamnesis (RR=1.886 [95% CI 1.29-2.74]), habitual miscarriage (RR=1.850 [95% CI 1.21-2.82]), a history of preeclampsia (RR= 1.922 [95% CI 1.31-2.80]), a history of RR (RR=3.502 [CI 2.37-5.16]).
Conclusions. The most significant clinical and anamnestic risk factors for the development of RRT are: arterial hypertension, overweight/obesity, anemia in the anamnesis, pre-eclampsia in the anamnesis, complicated labor in the anamnesis, habitual miscarriage, RRT in the anamnesis.
Keywords: pregnancy, preeclampsia, anemia, fetal growth retardation, risk factors.

REFERENCES

1. Bikmetova ES, Artyimuk NV. 2014. Informativnost klinicheskih i funktsionalnyh metodov diagnostiki zaderzhki rosta ploda. Mat i ditya v Kuzbasse 1(56):12-18.

2. Ganichkina MB, Mantrova DA, Kan NE. 2017. Vedenie beremennosti pri zaderzhke rosta ploda. Akusherstvo i ginekologiya 10:5-10. https://doi.org/10.18565/aig.2017.10.5-11

3. Degtyareva EA, Zaharova OA, Kufa MA, Kantemirova MG. 2018. Effektivnost prognozirovaniya i ranney diagnostiki zaderzhki rosta ploda. Rossiyskii vestnik perinatologii i pediatrii 63(6):37-45. https://doi.org/10.21508/1027-4065-2018-63-5-37-45

4. Ivih KA, Korosteleva ES. 2017. Kliniko-anamnesticheskaya harakteristika zhenschin s sindromom zaderzhki rosta ploda. Innova. 3(8):28-30.

5. Kazantseva EV, Dolgushina NV. 2012. Sovremennyie aspektyi patogeneza, diagnostiki i taktiki vedeniya beremennyih s sindromom zaderzhki rosta ploda. Zabaykalskii meditsinskii vestnik 2:170-177.

6. Kovalev EV, Zanko YuV, Trubkina TYu. 2014. Faktoryi riska zaderzhki rosta ploda, svyazannyie s sostoyaniem zdorovya i obrazom zhizni beremennoy zhenschinyi. Mat i ditya v Kuzbasse 4(59):24-28.

7. Plyusnina NN, Zaharova SYu, Pavlichenko MV. 2011. Analiz sostoyaniya zdorovya detey rannego vozrasta, rozhdennyih s zaderzhkoy vnutriutrobnogo rosta ploda. Vestnik Uralskoy meditsinskoi akademicheskoi nauki 4(37):59-62.

8. Belbasis L, Savvidou MD, Kanu C. 2016. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Medicine 14(1):147. https://doi.org/10.1186/s12916-016-0692-5; PMid:27677312 PMCid:PMC5039803

9. Unterscheider J, O' Donoghue Keelin, Malone FD. 2015. Guidelines of fetal growth restriction: A comparison of recent national publications. American Journal Perinatology 32(4):307-315. https://doi.org/10.1055/s-0034-1387927; PMid:25217738

10. Vijgen SM, Boers KE, Opmeer BC, Bijlenga D. 2013. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial). Eur J. Obstet Gynecol Reprod Biol. 170(2):358-363.